10 Pfizer marketing leaders

Vaccines, oncology, rare disease and neuroscience are the brand areas these Pfizer marketing leaders have worked in, three of them on vaccines, with titles from brand lead and global marketing director up to Senior Vice President, Global Marketing Lead. Drug and vaccine companies planning a launch, an HCP campaign or a split between global and US marketing can compare how Pfizer's brand teams handled those choices.

10 professionals1 companyData retrieved October 3, 2026

Professionals to explore

  1. Amy Buffetti Kreisberg

    LinkedIn

    Experience: Global Marketing Lead- Adult Vaccines Portfolio · Pfizer

    $539 per 30-minute call

    Amy Buffetti Kreisberg's Pfizer titles include Director - Global Marketing and Commercial Development roles in Immuno-Oncology (2017–2018) and Internal Medicine (2018–2021), Senior Director - Global Marketing Team Lead for Internal Medicine (2021–2023) and Vaccines (2023–2024), and Global Marketing Lead- Adult Vaccines Portfolio since 2024. Amy fits questions on marketing an adult vaccine portfolio globally.

    Is this you? Claim your profile and get paid for calls.

  2. Ana Maria Luque

    LinkedIn

    Experience: Vice President of Global Marketing Vaccines Franchise · Pfizer

    $1,211 per 30-minute call

    Ana Maria Luque is Vice President of Global Marketing Vaccines Franchise at Pfizer, a role since 2019, after Regional Vice President Marketing Vaccines at International Develop Markets, Europe-Asia (2016–2019). Ana Maria's earlier Pfizer roles include Country Manager Peru-Bolivia (2000–2005), Commercial VP of Established Products Emerging Markets Business Unit (2009–2013) and Country Manager Venezuela (2013–2016). Good for vaccine marketing at global, regional and country level.

    Is this you? Claim your profile and get paid for calls.

  3. Brigitte Ripert

    LinkedIn

    Experience: Global Marketing Director - Rare Diseases - Growth Hormone Franchise · Pfizer

    $471 per 30-minute call

    Brigitte Ripert, Global Marketing Director - Rare Diseases - Growth Hormone Franchise at Pfizer since 2023, works on launch uptake of the growth hormone product Ngenla and was integration lead for a new agency model. Brigitte's earlier Pfizer titles include Brand Director Europe for Inlyta's prelaunch and launch (2011–2014), Marketing Director for Ibrance's prelaunch and launch across Europe and other markets (2014–2018) and Global Marketing Director for Ibrance (2019–2023).

    Is this you? Claim your profile and get paid for calls.

  4. Carlos Moscol

    LinkedIn

    Experience: Former Vice President, Global Marketing Lead, Neuroscience and Pain · Pfizer

    $1,211 per 30-minute call

    As Vice President, Global Marketing Lead, Neuroscience and Pain at Pfizer (2016–2018), Carlos Moscol was leader of the Global Marketing team for a portfolio of neuroscience and pain phase 3 and in-line medicines, including tanezumab. Carlos was then Vice President, Regional Sales Leader, USA Midwest at Pfizer (2018–2020), and has been an Independent Business Advisor and Consultant since 2021 and a Consultant - COVAX at Gavi, the Vaccine Alliance (2022–2023).

    Is this you? Claim your profile and get paid for calls.

  5. Erling T. Donnelly

    LinkedIn

    Experience: Senior Vice President, Global Marketing Lead · Pfizer

    $2,019 per 30-minute call

    Erling T. Donnelly has been Senior Vice President, Global Marketing Lead at Pfizer since February 2026, and held Vice President, US Breast Cancer Franchise & Portfolio Marketing Lead (2021–2026) and Vice President, Hematology Franchise Lead (2024–2025) there, plus Oncology Lead, Sweden & Finland (2019) and Oncology Lead, United Kingdom (2019–2021). Erling led the Development team for IBRANCE and VIZIMPRO, which suits questions on taking an oncology drug from development into marketing.

    Is this you? Claim your profile and get paid for calls.

  6. Gloria Choi

    LinkedIn

    Experience: Oncology, VP, US PADCEV Brand Lead · Pfizer

    $1,010 per 30-minute call

    Gloria Choi became Oncology, VP, US PADCEV Brand Lead at Pfizer in April 2026, a role covering P&L management and a team of 7 FTEs building brand strategies across customer sets. Gloria was also Oncology, Interim US PADCEV Brand Lead (2025), Oncology, US Vepdegestrant Brand Lead (2024–2025) and Oncology, US IBRANCE Brand Lead (2022–2025). Three US oncology brand lead titles make Gloria a fit for how a US cancer brand plan is built.

    Is this you? Claim your profile and get paid for calls.

  7. Sandra Bunke-Koelblin

    LinkedIn

    Experience: Marketing Director Oncology · Pfizer

    $471 per 30-minute call

    Marketing Director Oncology at Pfizer since December 2025, Sandra Bunke-Koelblin leads teams across multiple indications and products and asks how oncology marketing can use AI responsibly, compliantly and with measurable impact. At Johnson & Johnson Innovative Medicine, Sandra was Marketing Lead Neuroscience (2019–2024) and Head of Transformation & Innovation Excellence (2024–2025). Useful for comparing oncology marketing at Pfizer and J&J.

    Is this you? Claim your profile and get paid for calls.

  8. Shera D. Gruen

    LinkedIn

    Experience: Former Vice President, Marketing, US and Global Vaccines · Pfizer

    $1,211 per 30-minute call

    Shera D. Gruen was Vice President Marketing Lead, U.S. Pediatric & Adolescent Vaccines (2021–2022) and then Vice President, Marketing, US and Global Vaccines (2022–2024) at Pfizer. Since leaving, Shera founded Gruen Advisory (2024–2025) and has been Senior Vice President at Lumanity since 2025. In their own words, Shera specializes in product launches, market access, commercialization and marketing strategy, a fit for vaccine launch planning.

    Is this you? Claim your profile and get paid for calls.

  9. Sonali Jasmin

    LinkedIn

    Experience: Senior Director, Global Marketing Excellence · Pfizer

    $505 per 30-minute call

    Sonali Jasmin has been Senior Director, Global Marketing Excellence at Pfizer since 2023, leading marketing strategy excellence for the Chief Marketing Office. Other Pfizer titles were Director, Global Marketing Inflammation & Immunology (2018–2021), Omnichannel Marketing Lead - Agile Team (2021–2022) and Senior Director, Launch Navigation (2022–2023), after SVP, Director of Strategy at ghg | greyhealth group (2017–2018). A fit for launch process and omnichannel questions.

    Is this you? Claim your profile and get paid for calls.

  10. Sophia Patel

    LinkedIn

    Experience: Global Marketing Director - Launch Lead, VELSIPITY · Pfizer

    $471 per 30-minute call

    Sophia Patel holds Global Marketing Director - HCP Strategy, Mevrometostat at Pfizer, a prostate cancer role since February 2026. For VELSIPITY, Sophia was Global Marketing Director - HCP and Patient Customer Experience (2022–2024) and Global Marketing Director - Launch Lead (2024–2026), and was earlier Senior Marketing Manager, US ELIQUIS HCP Indication Lead (2018–2020). The VELSIPITY launch lead title fits questions on how a global launch is planned.

    Is this you? Claim your profile and get paid for calls.

Choose the right perspective

For vaccine questions, Ana Maria Luque and Amy Buffetti Kreisberg hold current Pfizer vaccine roles, and Shera D. Gruen covers US and global vaccines through 2024. Gloria Choi, Sandra Bunke-Koelblin, Sophia Patel and Erling T. Donnelly fit oncology brand and launch work, Brigitte Ripert covers rare disease and Ibrance, Sonali Jasmin suits marketing excellence and omnichannel questions, and Carlos Moscol's neuroscience and pain role ended in 2018.

Questions to take into the conversation

  1. 01How does Pfizer divide work between global brand teams and US brand leads in the year before a launch?
  2. 02How do Pfizer's vaccine marketers plan campaigns differently for prescribers and for the public?
  3. 03When a Pfizer brand team changes its agency model or moves to omnichannel, what does it measure to know the change worked?

About this directory

This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.

Other perspectives in Pharmaceuticals